Donald Jensen to Retrospective Studies
This is a "connection" page, showing publications Donald Jensen has written about Retrospective Studies.
Connection Strength
0.153
-
Sticker shock and the price of new therapies for hepatitis C: is it worth it? Hepatology. 2014 Apr; 59(4):1246-9.
Score: 0.064
-
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology. 2006 May; 43(5):954-60.
Score: 0.037
-
The downstream financial effect of hepatology. Hepatology. 2005 May; 41(5):968-75.
Score: 0.035
-
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin. J Hepatol. 2015 Feb; 62(2):294-302.
Score: 0.017